REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 41 filers reported holding REGULUS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,000 | -20.0% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $5,000 | -50.0% | 15,000 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $10,000 | -50.0% | 15,000 | -37.5% | 0.00% | -50.0% |
| Q2 2021 | $20,000 | -45.9% | 24,000 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $37,000 | +15.6% | 24,000 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $32,000 | +166.7% | 24,000 | 0.0% | 0.01% | +100.0% |
| Q3 2020 | $12,000 | -14.3% | 24,000 | +20.0% | 0.00% | -20.0% |
| Q2 2020 | $14,000 | +55.6% | 20,000 | +5.3% | 0.01% | +25.0% |
| Q1 2020 | $9,000 | – | 19,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 1,985,472 | $3,097,000 | 1.60% |
| Endurant Capital Management LP | 2,376,557 | $3,707,000 | 0.97% |
| Sarissa Capital Management LP | 1,851,851 | $2,888,000 | 0.28% |
| NEA Management Company, LLC | 6,451,056 | $10,064,000 | 0.23% |
| Atom Investors LP | 337,228 | $526,000 | 0.09% |
| Ikarian Capital, LLC | 1,245,989 | $1,943,000 | 0.06% |
| GYL FINANCIAL SYNERGIES, LLC | 51,376 | $80,000 | 0.04% |
| Focused Wealth Management, Inc | 100,000 | $156,000 | 0.03% |
| Point72 Asset Management, L.P. | 3,215,436 | $5,016,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 141,629 | $221,000 | 0.01% |